RESMED INC - Common Stock (RMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
RMD on NYSE
Shares outstanding
146,467,184
Price per share
$240.87
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
91,512,423
Total reported value
$25,040,459,093
% of total 13F portfolios
0.02%
Share change
-588,826
Value change
-$136,746,309
Number of holders
931
Price from insider filings
$240.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RESMED INC - Common Stock (RMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 14% $5,476,630,365 20,007,417 The Vanguard Group 30 Sep 2025

As of 30 Sep 2025, 931 institutional investors reported holding 91,512,423 shares of RESMED INC - Common Stock (RMD). This represents 62% of the company’s total 146,467,184 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of RESMED INC - Common Stock (RMD) together control 45% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 13% 19,040,440 +1.6% 0.08% $5,211,939,642
BlackRock, Inc. 8.4% 12,277,966 -1.3% 0.06% $3,360,847,519
STATE STREET CORP 4.5% 6,549,164 -1% 0.06% $1,792,702,662
Bank of New York Mellon Corp 3.1% 4,552,916 -9.8% 0.22% $1,246,269,745
GEODE CAPITAL MANAGEMENT, LLC 2.9% 4,251,688 +0.87% 0.07% $1,159,544,500
MORGAN STANLEY 1.6% 2,313,138 -13% 0.04% $633,175,806
Invesco Ltd. 1.4% 2,108,763 -3.4% 0.09% $577,231,572
NORTHERN TRUST CORP 1.2% 1,697,882 -1% 0.06% $464,761,240
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.73% 1,067,643 +4.6% 0.05% $292,245,918
Legal & General Group Plc 0.65% 958,210 -1.4% 0.06% $262,290,821
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.62% 906,744 -13% 0.05% $248,203,036
FMR LLC 0.6% 880,306 +155% 0.01% $240,965,941
UBS Group AG 0.6% 873,530 +64% 0.05% $239,111,367
GOLDMAN SACHS GROUP INC 0.59% 860,791 +3.2% 0.03% $235,624,329
DIMENSIONAL FUND ADVISORS LP 0.58% 846,134 +6.2% 0.05% $231,586,653
BANK OF AMERICA CORP /DE/ 0.56% 823,624 -2.3% 0.02% $225,450,507
NORDEA INVESTMENT MANAGEMENT AB 0.54% 790,872 +3.5% 0.19% $217,386,987
PRICE T ROWE ASSOCIATES INC /MD/ 0.53% 772,187 +125% 0.02% $211,372,000
ROYAL BANK OF CANADA 0.48% 706,369 +35% 0.03% $193,354,000
DEUTSCHE BANK AG\ 0.43% 625,528 +23% 0.06% $171,225,780
JPMORGAN CHASE & CO 0.42% 617,464 +16% 0.01% $169,027,458
BARCLAYS PLC 0.4% 579,632 -22% 0.06% $158,662,667
Caisse de depot et placement du Quebec 0.39% 565,901 +28% 0.28% $154,904,079
Swedbank AB 0.37% 542,711 +25% 0.15% $148,556,281
CAPTRUST FINANCIAL ADVISORS 0.37% 537,623 +5.4% 0.3% $147,163,581

Institutional Holders of RESMED INC - Common Stock (RMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,428,981 $586,523,151 +$54,739,344 $240.87 141
2025 Q3 91,512,423 $25,040,459,093 -$136,746,309 $273.73 931
2025 Q2 92,309,428 $23,802,163,537 -$234,889,563 $258.00 911
2025 Q1 93,172,288 $20,835,839,281 +$660,932,088 $223.85 869
2024 Q4 89,975,494 $20,582,067,601 +$631,518,570 $228.69 853
2024 Q3 86,213,388 $21,029,303,083 +$210,216,200 $244.12 791
2024 Q2 85,453,036 $16,351,837,872 +$749,023,957 $191.42 767
2024 Q1 81,281,588 $16,087,716,055 +$226,197,089 $198.03 711
2023 Q4 181,900 $31,290,864 -$3,016,436 $172.02 8
2023 Q3 83,866,177 $12,392,166,611 -$1,756,114,895 $147.87 634
2023 Q2 93,572,930 $20,442,908,221 -$398,426,711 $218.50 712
2023 Q1 93,919,664 $20,563,174,477 +$84,796,301 $218.99 654
2022 Q4 95,066,352 $19,788,145,471 -$194,220,664 $208.13 705
2022 Q3 95,610,448 $20,884,672,355 -$39,705,081 $218.30 636
2022 Q2 87,633,015 $18,403,083,227 -$307,832,105 $209.63 650
2022 Q1 95,704,826 $23,227,951,608 +$473,695,377 $242.51 646
2021 Q4 93,454,070 $24,331,674,636 -$535,331,605 $260.48 693
2021 Q3 91,530,339 $24,122,730,141 -$134,019,756 $263.55 667
2021 Q2 95,540,186 $23,549,463,527 -$378,632,900 $246.52 644
2021 Q1 97,162,990 $18,848,999,109 -$166,236,049 $194.02 644
2020 Q4 96,166,753 $20,433,005,639 +$93,379,098 $212.56 641
2020 Q3 98,692,701 $16,916,133,512 -$314,729,713 $171.43 603
2020 Q2 100,394,083 $19,275,710,584 +$661,247,541 $192.00 559
2020 Q1 98,057,677 $14,447,268,542 +$118,111,122 $147.29 562
2019 Q4 97,581,225 $15,118,840,853 +$119,466,064 $154.97 546
2019 Q3 95,124,151 $12,847,995,207 +$73,757,355 $135.11 508
2019 Q2 95,822,842 $11,688,723,170 +$165,221,941 $122.03 470
2019 Q1 95,589,541 $9,936,820,452 -$36,491,599 $103.97 460
2018 Q4 97,445,749 $11,085,185,388 +$391,095,489 $113.87 484
2018 Q3 92,298,570 $10,643,240,468 +$168,987,479 $115.34 478
2018 Q2 90,857,050 $9,410,917,536 +$294,616,684 $103.58 450
2018 Q1 90,166,966 $8,876,954,075 +$133,134,401 $98.47 433
2017 Q4 88,880,271 $7,526,760,923 +$195,361,223 $84.69 404
2017 Q3 88,743,153 $6,828,886,650 +$166,640,241 $76.96 355
2017 Q2 86,633,823 $6,744,816,827 +$38,005,349 $77.87 330
2017 Q1 86,705,583 $6,239,446,547 +$813,854,994 $71.97 362
2016 Q4 87,936,469 $5,456,176,769 -$129,867,259 $62.05 352
2016 Q3 89,966,360 $5,826,828,461 +$154,717,947 $64.79 366
2016 Q2 86,931,363 $5,497,341,282 +$263,504,865 $63.23 354
2016 Q1 83,340,811 $4,816,188,452 +$32,594,651 $57.82 363
2015 Q4 82,595,224 $4,434,821,092 +$286,452,030 $53.69 341
2015 Q3 77,094,244 $3,918,232,578 +$122,223,751 $50.96 305
2015 Q2 73,259,605 $4,128,734,985 +$8,314,114 $56.37 307
2015 Q1 73,336,708 $5,259,466,915 -$62,627,888 $71.78 325
2014 Q4 74,749,641 $4,193,997,041 +$75,162,229 $56.06 306
2014 Q3 72,680,767 $3,581,353,417 -$144,641,951 $49.27 296
2014 Q2 75,588,962 $3,827,465,671 -$207,811,481 $50.63 308
2014 Q1 79,942,025 $3,572,812,050 +$5,450,052 $44.69 316